Hormonal and Reproductive Factors and the Risk of Bladder Cancer in Women.
From: Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA. mmcgrath@hsph.harvard.edu
American journal of epidemiology
- Publish Date: Feb 2006
- ISSN: 0002-9262
- Volume: 163
- Issue: 3
- Pages: 236-44
- Medium: Print
- Language: English
- Citation (JAMA): McGrath Monica, Michaud Dominique S, De Vivo Immaculata, et al. Hormonal and Reproductive Factors and the Risk of Bladder Cancer in Women.. Am. J. Epidemiol. Feb 2006;163:236-44
Abstract
Gender and cigarette smoking are among the most consistent predictors of bladder cancer risk. After adjustment for known risk factors, an excess risk remains for males, suggesting that other factors may be responsible for the gender differences. Given limited data on hormonal or reproductive factors and bladder cancer risk, the authors examined these factors among women in the US Nurses’ Health Study cohort. During 26 years of follow-up (1976-2002), 336 incident cases of bladder cancer were diagnosed. Cox proportional hazards models were used to estimate incidence rate ratios and 95% confidence intervals between hormonal and reproductive factors and bladder cancer risk. Postmenopausal women, compared with premenopausal women, were at increased risk (incidence rate ratio = 1.93, 95% confidence interval: 0.99, 3.78). For postmenopausal women, early age at menopause (/=50 years) was associated with a statistically significant increased risk of bladder cancer (incidence rate ratio = 1.63, 95% confidence interval: 1.20, 2.23). The association between age at menopause and bladder cancer risk was modified by cigarette smoking status (p for interaction = 0.01). The authors observed no significant associations of age at menarche, parity, age at first birth, and exogenous hormone use with bladder cancer risk. Findings suggest that menopausal status and age at menopause may play a role in modifying bladder cancer risk among women.
Mesh Headings (Keywords): Adult, Age Factors, Confidence Intervals, Contraceptives, Oral, Hormonal, Estrogen Replacement Therapy, Female, Humans, Menopause, Middle Aged, Nurses, Proportional Hazards Models, Prospective Studies, Questionnaires, Risk Assessment, Risk Factors, United States, Urinary Bladder Neoplasms
Check for Full Text / PubMed Unique Identifier (PMID): 16319290
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.